Disease Management & Health Outcomes

Acknowledgment
pp. 357-358(2)
Author: Adis International Limited,

How Should Functionally Equivalent Drugs be Reimbursed?: A Retrospective Analysis of Reimbursement for Epoetin-α and Darbepoetin-α in 2001–3 and the Cost Implications for CMS
pp. 359-370(12)
Authors: Kanavos, Panos G.; Saka, Ömer R.

Efficiency of Interventions in HIV Infection, 1994–2004
pp. 371-394(24)
Authors: Harling, Guy; Wood, Robin; Beck, Eduard J.

Education and Phone Follow-Up in Postmenopausal Women at Risk for Osteoporosis: Effects on Calcium Intake, Exercise Frequency, and Medication Use
pp. 395-404(10)
Authors: Schousboe, John T.; DeBold, Rowan C.; Kuno, Linda S.; Weiss, Thomas W.; Chen, Ya-Ting; Abbott, Thomas A.

Utilization and Medical Care Expenditures in Patients with Chronic Obstructive Pulmonary Disease: A Managed Care Claims Data Analysis
pp. 405-412(8)
Authors: Yu-Isenberg, Kristina S.; Vanderplas, Ann; Chang, Eunice Y.; Shah, Hemal

Consumer Knowledge of the Impact of a Change in Prescription Drug Benefit Design
pp. 413-420(8)
Authors: Feldman, Roger; Abraham, Jean; Davis, Linda; Carlin, Caroline

Cost Effectiveness of a Clinical Decision Support System Based on the Recommendations of the European Society of Cardiology and Other Societies for the Management of Hypercholesterolemia: Report of a Cluster-Randomized Trial
pp. 421-432(12)
Authors: Cobos, Albert; Vilaseca, Jordi; Asenjo, César; Pedro-Botet, Juan; Sánchez, Emilia; Val, Alicia; Torremadé, Eva; Espinosa, Cristina; Bergoñón, Salvador